Oppenheimer Maintained Perform on GoPro (GPRO) After Meeting with Management
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to Oppenheimer Maintained Perform on GoPro (GPRO) After Meeting with Management
September 17, 2015 9:04 AM EDT
Citi analysts are cutting near-term estimates on GoPro (NASDAQ: GPRO) but reiterated a Buy rating and $90 price target on GoPro (NASDAQ: GPRO), saying weak Q3 and Q4 results are largely priced in and HERO4 concerns create an attractive entry point.
The analysts noted that CFO Lazar confirmed at... More
September 14, 2015 12:10 PM EDT
After seeing tremendous pressure over the past few weeks, shares of GoPro (NASDAQ: GPRO) are up 4.4% Monday, benefiting from two items: 1. The WSJ posted a bullish-leaning Heard on the Street Column "Shredded GoPro Finally Looks Like a Deal"; 2. Northland... More
September 14, 2015 9:23 AM EDT
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) 33% HIGHER; confirmed late Friday that the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously to support the approval of Xtampza ER (oxycodone extended-release capsules) for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Raptor Pharma (NASDAQ: RPTP) 27.4% LOWER; announced topline... More
September 14, 2015 6:47 AM EDT
GoPro (Nasdaq: GPRO) shares are on watch following mixed commentary in the WSJ over the weekend.
The WSJ noted recent... More
